CancerVax Corporation Report issue

For profit Phase 2 Phase 3
Founded: Wilmington DE United States (1998)
Status: Acquired by Micromet (2003) → now Amgen (2012)

Organization Overview

First Clinical Trial
2003
NCT00052130
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CancerVax Corp | CancerVax Corporation